Biotechnology startup

Correlia Biosystems

Correlia Biosystems develops microscale tools that accelerate the rate of molecular interactions, allowing for measurements of biomolecules.

Funding reportedLast round: Undisclosed round

Biotechnology

What company datasets say Correlia Biosystems raised

Funding, as reported

Reported in all10.7Min the source's currency
Rounds10
Last roundUndisclosed round
Last round dateOct 2020
Investors listed7
Y CombinatorW18

Founders and team

From Correlia Biosystems's own website: 3 on the team.

  • Akwasi AporiPresident & CEO
  • M. Kursad ArazChief Technical Officer
  • Samuel TiaChief Science Officer

On 2 portfolio pages

Investors who name them

Each firm lists Correlia Biosystems on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Correlia Biosystems in front of investors. Or tell us what we have wrong.